![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication April 19, 2005.
Revised July 12, 2005.
Accepted for publication July 12, 2005.
Adenosine, an important signaling molecule in asthma, produces bronchoconstriction in asthmatics. Adenosine produces bronchoconstriction in allergic rabbits, primates, and humans by activating A1 adenosine receptors (AR). Effects of L-97-1, a water soluble, small molecule A1 AR antagonist were investigated on early and late phase allergic responses (EAR and LAR) in a hyper-responsive rabbit model of asthma. Rabbits were made allergic by intraperitoneal injections of House Dust Mite (HDM, 312 AU) extract within 24 h of their birth. Booster HDM injections were given weekly for one month, biweekly for 4 months and continued monthly thereafter. Hyper-responsivenessness was monitored by measuring lung dynamic compliance (Cdyn), following histamine or adenosine aerosol challenge in allergic rabbits. Hyper-responsive rabbits were subjected to aerosol of HDM (2500 AU), 1 h after intragastric administration of L-97-1 (10mg/kg) solution or an equivalent volume of saline. Cdyn was significantly higher following treatment with L-97-1 compared to untreated controls (p<0.05, n=5). Histamine PC30 was significantly higher (p<0.05, n=5) following L-97-1 at 24 h compared to histamine PC30 at 24 h following HDM. Adenosine PC30 was significantly higher at 15 min and 6 h following L-97-1 compared to control (p<0.05, n=5). L-97-1 showed strong affinity for human A1 ARs in radioligand binding studies and no inhibition towards human phosphodiesterase II, III, IV and V enzymes. These data suggest that L-97-1 produces a significant reduction of histamine or adenosine-induced hyper-responsive and HDM-induced EAR and LAR in rabbits by blocking A1 ARs and may be beneficial as an oral therapy for human asthma.
Key words:
A1 adenosine receptor, Adenosine, L-97-1, allergen, asthma, hyper-responsiveness
This article has been cited by other articles:
![]() |
R. A. Brown, G. W. Clarke, C. L. Ledbetter, M. J. Hurle, J. C. Denyer, D. E. Simcock, J. E. Coote, T. J. Savage, R. D. Murdoch, C. P. Page, et al. Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects Eur. Respir. J., February 1, 2008; 31(2): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nadeem, M. Fan, H. R. Ansari, C. Ledent, and S. Jamal Mustafa Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1335 - L1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Mustafa, A. Nadeem, M. Fan, H. Zhong, L. Belardinelli, and D. Zeng Effect of a Specific and Selective A2B Adenosine Receptor Antagonist on Adenosine Agonist AMP and Allergen-Induced Airway Responsiveness and Cellular Influx in a Mouse Model of Asthma J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1246 - 1251. [Abstract] [Full Text] [PDF] |
||||